Autentificare
NeuroPsy InfoHubÎnțelege · Sprijin · ProgresCere sprijin
← Toate temele

Depresie

Tristețe persistentă, lipsa energiei și a motivației.

106 articole
← Toate secțiunile

Studii și știri

PublicToțiPentru oricineSpecialiști
VârstăToate vârsteleCopiiTineriAdulțiVârstnici
StudiuDepresieÎncredere înaltă16.06.2026

Impact of difficult-to-treat depression for patients and society: a real-world study

This real-world cohort study of 3,941 patients examined clinical profiles and healthcare costs for major depressive disorder (MDD) and difficult-to-treat depression (DTD), with and without suicide risk, over 12 months. Patients presenting through emergency settings showed greater severity, comorbidities, suicide risk, and higher costs compared to those in outpatient settings, with DTD patients demonstrating poorer treatment outcomes overall.

StudiuDepresieÎncredere înaltă16.06.2026

Trends in Antidepressant Prescriptions for Children and Adolescents with Major Depressive Disorder in Japan (2010-2017)

This longitudinal study analyzed antidepressant prescription patterns for pediatric patients with MDD in Japan using health insurance claims data from 2010-2017. Findings showed increasing absolute prescription rates in adolescents (13-18 years), with selective serotonin reuptake inhibitors dominating, though the proportion of MDD patients receiving antidepressants actually declined over the period.

StudiuDepresieÎncredere bună16.06.2026

Psychotic major depressive disorder and REM sleep behavior disorder co-occurring with pineal cyst: adolescent case report with neuroimaging analysis

A 15-year-old girl with severe depression, psychotic features, and suicidal behavior was found to have a pineal cyst and rapid eye movement sleep behavior disorder on diagnostic evaluation. Treatment with adjusted psychiatric medications, electroconvulsive therapy, and psychotherapy resulted in significant clinical improvement across mood, psychotic, and sleep symptoms.

StudiuDepresieÎncredere bună16.06.2026

Medicine Is Awesome: A Critical Look at Factors Shaping Depression Treatment Thinking

This article examines how depression shifted from being understood as a psychosocial reaction to being framed as a neurochemical imbalance requiring medication, questioning whether this medicalization has led to overreliance on pharmacotherapy. The author argues for a more expansive biopsychosocial approach that acknowledges neurobiology while incorporating non-pharmaceutical treatments tailored to individual patient needs.

StudiuDepresieÎncredere înaltă16.06.2026

Psychological Needs Satisfaction and Depressive Symptoms in Parents of Autistic Children: A Cross-Lagged Panel Analysis

This study examined bidirectional relationships between basic psychological needs satisfaction (autonomy, competence, relatedness) and depressive symptoms in 178 Chinese parents of autistic children over a three-month period. Results showed parenting stress mediates both the negative effects of depression on psychological needs and the protective effects of autonomy satisfaction on mental health.

PresăDepresieÎncredere bună15.06.2026

Depression may involve impaired energy production in brain cells

Research reveals that brain and blood cells in people with major depressive disorder show abnormal energy metabolism—producing excess energy molecules at rest but failing to scale up production when needed. This cellular energy dysregulation may underlie depression symptoms like fatigue and low motivation, offering potential insights for diagnosis and treatment development.

PresăDepresieÎncredere bună15.06.2026

Adolescent Diet Patterns Associated with Mental Health Outcomes: A Review of Research

A meta-review of approximately 20 studies indicates that whole dietary patterns correlate with adolescent mental health, with healthier diets associated with fewer depressive symptoms and poor eating habits linked to greater psychological distress. The research emphasizes holistic dietary patterns over isolated nutrients as more consistently beneficial during critical neurodevelopmental periods.

PresăDepresieÎncredere bună15.06.2026

Harvard scientists link gut bacteria to depression through hidden inflammation trigger

Researchers identified that Morganella morganii, a gut bacterium, produces an inflammation-triggering molecule when exposed to common pollutants, potentially contributing to depression via immune mechanisms. The discovery suggests new treatment approaches targeting immune system pathways rather than exclusively targeting brain chemistry.

PresăDepresieÎncredere bună15.06.2026

New psychedelic-like drugs could treat depression without making you trip

UC Davis researchers developed novel compounds that activate serotonin receptors associated with neuroplasticity and mental health in animal models, without producing hallucinations. The work represents early-stage discovery that may eventually inform treatments for depression, PTSD, and addiction.

PresăDepresieÎncredere bună15.06.2026

Genetic Testing for Personalized Antidepressant Selection

Researchers from Nordic and German institutions are developing DNA-based testing using polygenic risk scores to predict antidepressant medication effectiveness for depression and anxiety patients. This pharmacogenomic approach analyzes genetic variations associated with mental health conditions and medication response to potentially reduce treatment trial-and-error.

StudiuDepresieÎncredere înaltă15.06.2026

Bright Light Therapy in Psychiatric Disorders: Mechanisms, Clinical Procedures and Evidence

Bright light therapy (BLT) is a evidence-based intervention that regulates mood by influencing circadian rhythms through light-sensitive retinal pathways to the suprachiasmatic nucleus. Strong clinical evidence supports BLT for seasonal affective disorder and major depressive disorder, with emerging benefits for bipolar disorder and insomnia, demonstrating excellent tolerability.

StudiuDepresieÎncredere înaltă15.06.2026

FIGO Best Practice Recommendations for Mental Health in Menopausal Women

International Federation of Gynecology and Obstetrics guidelines address mental health during menopause, identifying anxiety and depression as prevalent during perimenopause and recommending individualized treatment including cognitive-behavioral therapy, specific antidepressants (escitalopram, venlafaxine), and hormone therapy. The recommendations emphasize early detection through primary care training and highlight that mental health issues during menopause are often overlooked in low- and middle-income countries.

StudiuDepresieÎncredere înaltă15.06.2026

Neural signaling mechanisms in depression: from monoamine hypotheses to emerging rapid-acting antidepressants

This review examines depression neurobiology across classical and contemporary frameworks, discussing how traditional monoaminergic theories guided SSRIs and SNRIs while highlighting their limitations in treatment response and side effects. Recent discoveries of ketamine and psychedelic compounds have revealed alternative mechanisms involving glutamate signaling and synaptic plasticity, prompting re-evaluation of mechanistic models and circuit-level approaches to developing safer, more effective therapies.

StudiuDepresieÎncredere înaltă15.06.2026

Baseline Depressive Symptom Profiles Associated with Remission in Major Depression: PANDORA Trial Analysis

This secondary analysis of 215 adults with major depression found that 53% achieved remission at 12 weeks on antidepressants, with higher baseline severity and specific symptoms (suicidal ideation, psychomotor retardation, hypochondriasis) predicting lower remission odds. Sex differences emerged, with psychomotor retardation and suicidal ideation predicting non-remission in women, while hypochondriasis was the key marker in men.

StudiuDepresieÎncredere înaltă15.06.2026

Fluoxetine-induced neurogenesis and chronic antidepressant effects requires the dopamine D2 receptor

This study demonstrates that the dopamine D2 receptor (D2R) is essential for the long-term therapeutic effects of fluoxetine (an SSRI) on mood and hippocampal neurogenesis in mouse models of depression. The research reveals that D2R signaling through beta-arrestin 2 and BDNF regulation is crucial for chronic antidepressant action, though not required for acute responses to the drug.

StudiuDepresieÎncredere înaltă15.06.2026

Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder: Neurobiological Mechanisms and Clinical Translation

This scoping review examines scientific evidence for rTMS and related techniques (theta-burst stimulation, deep TMS) as therapeutic approaches for treatment-resistant depression, evaluating their effectiveness and safety across clinical trials and laboratory studies. rTMS applied to the prefrontal cortex demonstrates significant antidepressant effects with generally mild, transient adverse effects, and research indicates it produces neurobiological changes in brain connectivity and neurotransmitter systems.

StudiuDepresieÎncredere înaltă15.06.2026

A Review of Translational Behavioral Assays in Depression Research

This systematic review identified 10 behavioral tests with comparable human and rodent versions that measure depressive symptoms across species, including assays of valence systems, affective bias, and cognitive function. The translational approach bridges animal and human research paradigms to advance understanding of depression neurobiology and improve treatment development.